Browsing: Conditions

Mich. (News 10) – Potter Park Zoo has announced the death of Kota, a 19-year-old lion who was suffering from severe spinal disease

Morehead State University has received a $50,000 grant to enhance its Bachelor of Science in Nuclear Medicine Technology program, supporting the University’s efforts to prepare highly skilled imaging professionals for Kentucky’s healthcare workforce

On the same day Florida reported its second death in two weeks from Vibrio vulnificus, the so-called “flesh-eating bacteria,” Louisiana reported five

ORANGE BEACH, AL – If you’re planning a beach trip this summer, doctors say there’s one more danger to know about — a rare bacteria in warm coastal waters that has already killed at least seven people along the Gulf Coast this year

CNBC Cures is proudly under AstraZeneca Rare Disease, whose support enables our journalism to elevate stories that advance research, innovation and patient care in rare diseases

Greenville, N.C. – The American Heart Association/American Stroke Association has awarded all nine ECU Health hospitals Get With The Guidelines® achievement awards for demonstrating commitment to following up-to-date, research-based guidelines for the treatment of heart disease, stroke and diabetes, ultimately leading to more lives saved, shorter recovery times and fewer readmissions to the hospital

When Amber Covington first came to the ShelbyCares Health Hub, her A1C — a measure of average blood sugar — was 12.9, a level indicating diabetes. But after working with certified health coach Belinda Gray, Amber’s A1C was down to 7.3, a big step on her journey to improve her health

A so-called flesh-eating bacterium that thrives in warm seawater has killed at least seven people this year along the Gulf Coast, officials said

A recent CRS report examines a fundamental tension in federal health law that Congress and the Trump administration must navigate. The Emergency Medical Treatment and Active Labor Act (EMTALA), enacted in 1986 to prevent hospitals from refusing care to poor or uninsured patients, sits at the center of a conflict between federal emergency-care requirements and…

Drugmakers and advocacy groups are eyeing the FDA’s reconsideration of rare disease treatments in the coming months, searching for signals of a shift on products that struggled to secure approval under previous leadership